NUCLEINSÄURE-ISOLATION

Patent europeic · EP1345952 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP1345952
Numer da la dumonda
EP01270542
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
14-12-2001
Publitgà
24-09-2003
Concedì
24-11-2004
Stritgà
31-12-2008
Motiv
Taxa annuala betg pajada
Classas IPC
C07H 1/08 (2006.01)
C07C 229/12 (2006.01)
C07C 233/47 (2006.01)
C07C 229/16 (2006.01)
C07D 295/08 (2006.01)
Prioritad
US 736632 14.12.2000
Dumonda PCT
PCT/GB2001/005524 14.12.2001
Publicaziun PCT
WO2002/048164 20.06.2002
Derivà da
EP04017291
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 22-07-2009

    Stritgà, taxa betg pajada

    Published in Swissreg on 22.07.2009

  2. 15-02-2006

    Transferì

    Owner
    DNA Research Innovations Limited, Sittingbourne Research Centre,, Building 740,, Heeley Close, Sittingbourne ME9 8HL, United Kingdom → INVITROGEN CORPORATION, 1600 Faraday Avenue, Carlsbad, CA 92008, USA

    Published in +pat+ No 3 in 2006

  3. 30-11-2004

    Concedì

    Published in +pat+ No 22 in 2004

Partidas

Possessur

Invitrogen Corporation

INVITROGEN CORPORATION

1600 Faraday Avenue, Carlsbad, CA 92008, US

Inventur

BAKER, Matthew, John

Maidstone, Kent ME15 9UJ, GB

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.